Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers

Psychopharmacology

Volumn 208, Issue 1, 2010, Pages 37-44

  George, David Ted ^a   Herion, David W ^a   Jones, Cheryl L ^a   Phillips, Monte J ^a   Hersh, Jacqueline ^a   Hill, Debra ^a   Heilig, Markus ^a   Ramchandani, Vijay A ^a   Geyer, Christopher ^b   Spero, David E ^b   Singley, Erick D ^a   O'Malley, Stephanie S ^c   Bishai, Raafat ^d   Rawlings, Robert R ^a   Kunos, George ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d International Clinical Development Oncology   (United States)

Author keywords

Alcohol; Alcohol self administration; CB1 receptor antagonist; Endocannabinoids; Heavy drinkers; Rimonabant (SR141716)

Indexed keywords

ALCOHOL; CORTICOTROPIN; HYDROCORTISONE; PLACEBO; RIMONABANT;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ANGER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HUMAN; MALE; PANIC; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE; SUICIDAL IDEATION;

ADRENOCORTICOTROPIC HORMONE; ADULT; ALCOHOL DRINKING; ALCOHOLISM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCORTISONE; MALE; MOTIVATION; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; REWARD; SELF ADMINISTRATION;

EID: 72649096719     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1704-3     Document Type: Article

References (30)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC
2. M Arnone J Maruani F Chaperon MH Thiebot M Poncelet P Soubrie FG Le 1997 Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors Psychopharmacology 132 104 106 10.1007/s002130050326 1:CAS:528:DyaK2sXkvFKjtb8%3D 9272766 (Pubitemid 27303746)
3. JF Cheer KM Wassum LA Sombers ML Heien JL Ariansen BJ Aragona PE Phillips RM Wightman 2007 Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation J Neurosci 27 791 795 10.1523/JNEUROSCI.4152-06. 2007 1:CAS:528:DC%2BD2sXhs1WrsbY%3D 17251418 (Pubitemid 46174497)
4. A Cippitelli A Bilbao AC Hansson AI Del W Sommer M Heilig M Massi FJ Bermudez-Silva M Navarro R Ciccocioppo FR de Fonseca 2005 Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats Eur J NeuroSci 21 2243 2251 10.1111/j.1460-9568.2005.04056.x 15869521 (Pubitemid 40695249)
5. G Colombo R Agabio M Fa L Guano C Lobina A Loche R Reali GL Gessa 1998 Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716 Alcohol Alcohol 33 126 130 1:CAS:528: DyaK1cXivFSlt70%3D 9566474
6. G Colombo S Serra G Brunetti R Gomez S Melis G Vacca MM Carai L Gessa 2002 Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats Psychopharmacology 159 181 187 10.1007/s002130100887 1:CAS:528:DC%2BD38XisVKlurw%3D 11862347 (Pubitemid 34146562)
7. V DiMarzo I Matias 2005 Endocannabinoid control of food intake and energy balance Nat Neurosci 8 585 589 10.1038/nn1457 1:CAS:528:DC%2BD2MXjsFyktbg%3D (Pubitemid 40594198)
8. D Economidou L Mattioli C Cifani M Perfumi M Massi V Cuomo L Trabace R Ciccocioppo 2006 Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats Psychopharmacology (Berl) 183 394 403 10.1007/s00213-005-0199-9 1:CAS:528:DC%2BD2MXht1Knt7jM (Pubitemid 41721140)
9. CS Freedland AL Sharpe HH Samson LJ Porrino 2001 Effects of SR141716A on ethanol and sucrose self-administration Alcohol Clin Exp Res 25 277 282 10.1111/j.1530-0277.2001.tb02209.x 1:CAS:528:DC%2BD3MXhsVyltbo%3D 11236843
10. JE Gallate T Saharov PE Mallet IS McGregor 1999 Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist Eur J Pharmacol 370 233 240 10.1016/S0014-2999(99)00170-3 1:CAS:528: DyaK1MXivVejsrs%3D 10334497 (Pubitemid 29192867)
11. AC Hansson FJ Bermudez-Silva H Malinen P Hyytia I Sanchez-Vera R Rimondini FF de Rodriguez G Kunos WH Sommer M Heilig 2007 Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference Neuropsychopharmacology 32 117 126 10.1038/sj.npp.1301034 1:CAS:528: DC%2BD28XhtlSqtbrP 16482090 (Pubitemid 44967790)
12. M Heilig M Egli 2006 Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms Pharmacol Ther 111 855 876 10.1016/j.pharmthera.2006.02.001 1:CAS:528:DC%2BD28Xns1SksL8%3D 16545872 (Pubitemid 44118437)
13. MA Huestis DA Gorelick SJ Heishman KL Preston RA Nelson ET Moolchan RA Frank 2001 Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716 Arch Gen Psychiatry 58 322 328 10.1001/archpsyc.58.4.322 1:STN:280:DC%2BD3M3itVGitA%3D%3D 11296091 [see comment]
14. BL Hungund I Szakall A Adam BS Basavarajappa C Vadasz 2003 Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens J Neurochem 84 698 704 10.1046/j.1471-4159.2003.01576.x 1:CAS:528: DC%2BD3sXht1amsbo%3D 12562514 (Pubitemid 36176928)
15. JA Lopez-Moreno G Gonzalez-Cuevas FF de Rodriguez M Navarro 2004 Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55, 212-2 during alcohol deprivation J Neurosci 24 8245 8252 10.1523/JNEUROSCI.2179-04.2004 1:CAS:528:DC%2BD2cXotVynt7k%3D 15385608 (Pubitemid 39280804)
16. PJ McLaughlin K Winston L Swezey A Wisniecki J Aberman DJ Tardif AJ Betz K Ishiwari A Makriyannis JD Salamone 2003 The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats Behav Pharmacol 14 583 588 10.1097/00008877-200312000- 00002 1:CAS:528:DC%2BD3sXps1Kjsrw%3D 14665975
17. M Naassila O Pierrefiche C Ledent M Daoust 2004 Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice Neuropharmacology 46 243 253 10.1016/j.neuropharm.2003. 09.002 1:CAS:528:DC%2BD3sXpvVWgsL0%3D 14680762 (Pubitemid 37532832)
18. SS O'Malley S Krishnan-Sarin C Farren R Sinha MJ Kreek 2002 Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis Psychopharmacology (Berl) 160 19 29 10.1007/s002130100919 (Pubitemid 34169822)
19. P Pacher S Batkai G Kunos 2006 The endocannabinoid system as an emerging target of pharmacotherapy Pharmacol Rev 58 389 462 10.1124/pr.58.3.2 1:CAS:528:DC%2BD28XhtVOhtLfO 16968947 [Review] [1332 refs] (Pubitemid 44394908)
20. M Poncelet J Maruani R Calassi P Soubrie 2003 Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice Neurosci Lett 343 216 218 1:CAS:528:DC%2BD3sXktFWls78%3D 12770700
21. S Rosner S Leucht P Lehert M Soyka 2008 Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes J Psychopharmacol (Oxf) 22 11 23 10.1177/0269881107078308
22. Sobell LC, Sobell MB (1992) Timeline follow-back: a technique for assessing self-reported ethanol consumption. In: Allen J, Litten RZ (eds) Measuring Alcohol Consumption: Psychosocial and Biological Methods. Humana Press, Totowa, NJ, pp 41-72
23. M Soyka G Koller P Schmidt OM Lesch M Leweke C Fehr H Gann KF Mann 2008 Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial J Clin Psychopharmacol 28 317 324 10.1097/JCP.0b013e318172b8bc 1:CAS:528: DC%2BD1cXmvFehu74%3D 18480689
24. Statsoft I (2005) STATISTICA (data analysis software system). Statsoft I, Tulsa
25. MA Steiner CT Wotjak 2008 Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis Prog Brain Res 170 397 432 10.1016/S0079-6123(08)00433-0 1:CAS:528:DC%2BD1cXht1CjtrbL 18655899 (Pubitemid 352010245)
26. JT Sullivan K Sykora J Schneiderman CA Naranjo EM Sellers 1989 Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-AR) Br J Addict 84 1353 1357 10.1111/j.1360-0443.1989. tb00737.x 1:STN:280:DyaK3c%2FovFKnsg%3D%3D 2597811
27. PK Thanos ES Dimitrakakis O Rice A Gifford ND Volkow 2005 Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors Behav Brain Res 164 206 213 10.1016/j.bbr.2005.06.021 1:CAS:528:DC%2BD2MXhtVartr7O 16140402 (Pubitemid 41337875)
28. S Turpault V Kanamaluru GF Lockwood D Bonnet J Newton 2006 Rimonabant pharmacokinetics in healthy and obese subjects Clin Pharmacol Ther 79 50 10.1016/j.clpt.2005.12.177
29. L Wang J Liu J Harvey-White A Zimmer G Kunos 2003 Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice Proc Natl Acad Sci U S A 100 1393 1398 10.1073/pnas.0336351100 1:CAS:528:DC%2BD3sXhtF2gu7c%3D 12538878 (Pubitemid 36184012)
30. EM Weerts YK Kim GS Wand RF Dannals JS Lee JJ Frost ME McCaul 2008 Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects Neuropsychopharmacology 33 653 665 10.1038/sj.npp.1301440 1:CAS:528:DC%2BD1cXmsFSmtA%3D%3D 17487229